Physician profile
Danielle Grant
NPI 1174325104
$693.97
in general payments reported to CMS, 2019-2025
17 companies · $694 in 2025
The $694 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $100.60 | 2025 | |
| Lundbeck LLC | $89.14 | 2025 | Vyepti, Rexulti |
| Novo Nordisk INC | $58.34 | 2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $56.06 | 2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $52.38 | 2025 | Trelegy Ellipta |
| Astellas Pharma US INC | $51.05 | 2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $45.16 | 2025 | Airsupra, Breztri |
| Boston Scientific Corporation | $43.62 | 2025 | Cds - Mct/Cem Monitoring |
| Exact Sciences Corporation | $35.14 | 2025 | The Cologuard Plus Collection Kit |
| Inspire Medical Systems, INC. | $27.47 | 2025 | Inspire |
| Otsuka America Pharmaceutical, INC. | $25.83 | 2025 | Rexulti |
| Dexcom, INC. | $22.96 | 2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $19.19 | 2025 | Gvoke Hypopen |
| Corcept Therapeutics | $17.79 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $17.76 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.26 | 2025 | Caplyta |
| Tris Pharma INC | $14.22 | 2025 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.